


20 ans de Genopole : le biocluster veut participer à la constitution de filières pour l’innovation en santé et en environnement

Vygon Group joins forces with EFCNI to mark 10th World Prematurity Day

Alizé Pharma 3 moves forward with building a transatlantic biopharmaceutical company focused on rare endocrine and metabolic diseases

Sofradir elected to Photonics21 Board of Stakeholders

GamaMabs Pharma to present new data on GM102 at two upcoming scientific conferences in November

Nosopharm appoints Dr Sarah Gould as chief development officer

Medicen Paris Region s’inscrit dans des projets ambitieux d’Intelligence Artificielle appliquée à la santé

Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes
